drugset / Trial / NCT05296460

DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS

NCT05296460

Phase 4 Unknown 30 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

Acne vulgaris, a chronic inflammatory skin disorder, is one of the most prevalent diseases that effects more than 80% of the population worldwide . A variety of factors such as genetics, hormones, infections, as well as environmental factors have been identified as the causes of acne development . Acne usually generates as a result of blockage in the pilosebaceous unit (including hair follicle, hair shaft, and sebaceous gland) due to the over-produced sebum by sebaceous gland, which further triggers the excessive proliferation of the bacterium Propionibacterium acnes (P. Acnes).

Timeline

Start
2022-09-01
Primary completion
2023-10
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule 7.5 % Topical
Subject Trichloroacetic acid Small molecule 20 % Topical

Indications